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ABSTRACT
MODULATION OF MACROPHAGE RESPONSES TO BORRELIA BURGDORFERI
IN ACUTE MURINE LYME CARDITIS
MAY 2009
CHRIS M. OLSON JR.
B.S., UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE
Ph.D., UNIVERSITY OF MASSACHUSETTS, AMHERST
Directed by: Professor Juan Anguita

The Lyme disease spirochete Borrelia burgdorferi is the only known human
pathogen that directly activates invariant natural killer T (iNKT) cells. The number and
activation kinetics of iNKT cells vary greatly among different strains of mice. Here, we
report the role of the iNKT cell response in the pathogenesis of Lyme disease using
C57BL/6 (B6) mice, a strain with optimal iNKT cell activation that is resistant to the
development of spirochetal-induced inflammation. During experimental infection of B6
mice with B. burgdorferi, iNKT cells localize to the inflamed heart where they are
activated by CD1d-expressing macrophages. Activation of iNKT cells in vivo results in
the production of IFNγ, which we demonstrate controls the severity of murine Lyme
carditis by at least two mechanisms. First, IFNγ greatly enhances the recognition of B.
burgdorferi by macrophages, leading to increased phagocytosis of the spirochete.
Secondly, IFNγ activation of macrophages increases the surface expression of CD1d,
thereby facilitating further iNKT activation. Collectively, our data demonstrate that in the
resistant background, B6, iNKT cells modulate acute murine Lyme carditis through the
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action of IFNγ, which appears to self-renew through a positive feedback loop during
infection.
Inflammation during infection with B. burgdorferi is dependent on the ability of
the spirochete to evade local mechanisms of clearance. Even though macrophages are the
main infiltrating cell during Lyme carditis, the identification of a receptor capable of
mediating phagocytosis of B. burgdorferi has been elusive. Here, we demonstrate that the
integrin CR3 is able to mediate binding to the spirochete and facilitate phagocytosis in a
complement-dependent and independent manner. Expression of CR3, but not CR4, in
CHO cells markedly enhanced their capacity to interact with B. burgdorferi, in the
absence and presence of complement opsonization. Furthermore, the interaction between
CR3 and B. burgdorferi is dependent on the metal-ion-dependent adhesion site (MIDAS)
and could be blocked with EDTA. Inhibition of CR3 with blocking antibody was able to
completely abrogate phagocytosis of B. burgdorferi by the macrophage-like RAW264.7
cells and partially block uptake by bone marrow-derived macrophages (BMMs), a finding
that was recapitulated with CD11b-deficient BMMs. We further show that activation with
recombinant IFNγ increases the transcription of CD11b and CD18, which correlates with
increased surface expression of CR3, and that the effect of IFNγ on the phagocytosis of
B. burgdorferi is circumscribed to CR3 activity, because inhibition of CR3 is able to
completely diminish the effect of IFNγ on the phagocytosis of the B. burgdorferi. Lastly,
our results demonstrate that CR3 is a negative regulator of proinflammatory cytokine
induction in macrophages responding to B. burgdorferi. Overall, our data demonstrate
roles for CR3 in the binding, phagocytosis and proinflammatory cytokine elicited by B.
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burgdorferi and shed light on the role of IFNγ in mediating the clearance of the
spirochete during Lyme disease.
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CHAPTER I
THE ROLE OF Vα14-Jα18 INVARIANT NKT CELLS DURING LYME
BORRELIOSIS

Introduction

Lyme disease was first discovered in 1976 as a tick-borne spirochetosis affecting
a cluster of children in Lyme, Connecticut. In 1982 Dr. Willy Burgdorfer and colleagues
identified the agent of Lyme disease as a new Gram-negative, extracellular bacterium
belonging to the eubacteria phylum of spirochetes (24). This spirochete was named
Borrelia burgdorferi. Since then, it has been established that at least three species of the
genus Borrelia are agents of Lyme disease. These include B. burgdorferi sensu stricto, B.
afzelii and B. garinii, which are collectively referred to as B. burgdorferi sensu lato (5,
25). Eight minimally pathogenic or nonpathogenic genospecies of B. burgdorferi have
been identified, which geographically span the United States and Eurasia (Table 1.1) (45,
67, 81, 90, 91, 110, 134). B. burgdorferi sensu stricto is the etiologic agent of Lyme
disease in the United States and other parts of the world, while B. afzelii and B. garinii
are agents of Lyme disease that are restricted to Europe and Asia (5, 25). Infection with
Lyme disease-causing spirochetes has also been observed in Japan, Russia and China. In
the United States, transmission of the spirochete is by hard-bodied ticks of the Ixodes
complex, mainly I. scapularis and I. pacificus. Importantly, Lyme disease is the most
commonly reported arthropod-borne disease in the United States and Europe.
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Enzootic life cycle of B. burgdorferi

B. burgdorferi and its associated genospecies have complex enzootic life cycles
involving ticks of the Ixodes complex and a wide range of mammals (139). Ixodid ticks
have three feeding periods during their usual 2-year life cycle. During these periods, ticks
feed to repletion on the blood of certain vertebrate hosts. In the case of I. scapularis,
larval ticks feed during the late summer and then molt into a nymphal tick, which feeds
the following year during late spring or early summer. Larval and nymphal I. scapularis
ticks feed on certain rodents, including the white-footed mouse and chipmunk (Figure
1.1) (83, 88). The life cycle of B. burgdorferi depends on horizontal transmission,
meaning that the larval and nymphal tick must share a host. As such, during late spring or
early summer rodents are infected with B. burgdorferi by infected nymphs, and in the late
summer, larvae acquire B. burgdorferi from the infected rodents. Adult I. scapularis feed
on large mammals during the fall, in particular, the white-tailed deer, and then lay eggs,
which persist through the winter and spring and hatch the following summer (Figure 1.1)
(136). Although the white-tailed deer is not directly involved in the enzootic life cycle of
B. burgdorferi, it is required for survival of I. scapularis (136). Humans are not involved
in the maintenance of B. burgdorferi in the wild, and thus are not part of the enzootic life
cycle of the spirochete. Instead, humans are an incidental host, which acquire the
infection from infected ticks questing for their next blood meal. Most human infections
occur during late spring or early summer, which is coincedent with the nymphal feeding
period.
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The vector ecology of B. burgdorferi and genospecies is regional. For example, in
the Western United States, two intersecting enzootic cycles are required for human
infection with B. burgdorferi. One cycle, involving the dusky-footed wood rat and I.
spinipalpis ticks, which do not bite humans, maintain the B. burgdorferi in nature. The
other cycle, involves dusky-footed wood rats and I. pacificus ticks, which are less often
infected, but which do bite humans (23). In the southeastern United States, nymphal I.
scapularis ticks feed primarily on infection-resistant lizards, and as a consequence, the
prevalance of B. burgdorferi in nature is low, along with the incidence of human
infection (77). In Europe, B. burgdorferi sensu lato is maintained in nature by I. ricinus;
however, the preferred host of these ticks is being debated because they feed on more
than 300 animal species (50). In Asia, the enzootic life cycle of Borrelia species involve
larval and nymphal I. persulcatus ticks, which feed on voles, shrews and birds and adult
ticks, which feed on larger animals (72).

The biology of B. burgdorferi

The B. burgdorferi (strain B31) genome has been completely sequenced. It has a
single linear chromosome of around one megabase and 21 plasmids, many of which are
indispensable (44). B. burgdorferi does not possess LPS-encoding genes (44) or any
recognizable toxins, despite the ability of this microorganism to cause human disease. In
addition, B. burgdorferi express very few proteins with recognizable biosynthetic
activity, and therefore, the organism depends on the host for most of its nutritional
requirements.
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Borrelia burgdorferi is approximately 0.2 to 0.3 µm by 20 to 30 µm, and is a
vigorously motile bacterium due to the presence of periplasmic flagella, which run
lengthwise between the peptidoglycan layer and the outer membrane. Flagella originate at
the ends of the spirochete where they are anchored to the cytoplasmic membrane and
wind around the protoplasmic cylinder (Figure 1.2B) (49). The presence of flagella also
gives B. burgdorferi its distinctive corkscrew shaped morphology and may be important
in the invasiveness of the spirochete into target tissues and organs (Figure 1.2A).

One of the most striking features of the Borrelia genome is the large number of
open reading frames (ORF's) encoding lipoproteins (44), including outer-surface
lipoproteins (Osp's) A through F and VLsE, an important lipoprotein that undergoes
antigenic variation and is involved in immune evasion (144). Five percent of the
chromosomal ORF's encode putative lipoproteins, whereas 14.5% to 17% of the
functionally complete ORFs contained in these B. burgdorferi plasmids encode
lipoproteins (44). Lipoproteins are distributed throughout the outer leaflet of the innermembrane (cytoplasmic membrane) and both the inner and the outer leaflets ouf the
outer-membrane. The abundant lipoprotein coding potential of B. burgdorferi suggests
that lipoproteins may be important for the survival of the spirochete. During tick feeding,
as a result of increased temperature and nutrient availability, as well as reduced pH,
expression of several B. burgdorferi lipoproteins is augmented (3).
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Transmission of B. burgdorferi into the human host

The Ixodid tick, unlike any other hematophagous arthropod vector, engorges for 4
to 8 days on the vertebrate host in order to feed to repletion (123). Transmission of B.
burgdorferi into the human host requires between 40 and 48 hours following I. scapularis
attachment. During the acquisition of the bloodmeal, B. burgdorferi differentially
regulates several genes that enable the passage from the midgut through the hemolymph
and into the salivary glands (3). For instance, the lipoprotein OspA is expressed at high
levels in the gut of the unfed tick, but is downregulated upon tick feeding, while the
expression of OspC increases 90 fold (128). OspA is involved in the attachment of B.
burgdorferi to the midgut of the tick through its interaction with the tick receptor
TROSPA, which protects the spirochete from the digestive and defense pathways of the
tick (105-107). Thus, downmodulation of OspA facilitates the transmission of the
spirochete into the human host (106). Furthermore, upregulation of OspC is required for
the survival of the spirochete in the human host during the initial phase of infection (54,
108), although its exact role both in the tick and the mammalian host remains unclear (54,
108).

The first barrier B. burgdorferi encounters during its colonization of the human
host is serum complement, which occurs during its deposition into the dermis.
Complement is a collection of serum proteins and cell surface receptors that are involved
in the early response to pathogens, including B. burgdorferi (80). Destruction of
microorganisms via complement involves the formation of a pore in the microbial cell
membrane by the membrane attack complex (MAC), which results in the lysis of the
5

organism. Three different pathways elicit complement activation: the classical (antigen
antibody-mediated), lectin and alternative (pathogen surface) pathway. These pathways
converge at the level of C3 convertase, a protease that cleaves complement component
C3 into C3a and C3b. As a result, C3b can 1) bind to the surface of the bacteria and
facilitate internalization of the spirochete via opsonization or 2) bind C3 convertase and
facilitate the deposition of downstream components onto the bacterial surface resulting in
the formation of the MAC and lysis of the cell.

B. burgdorferi activates the classical and alternative pathways of the complement
cascade (69). The activation of complement has been associated with decreases in
spirochetal numbers in different tissues of infected mice (80), indicating the importance
of the complement system early in B. burgdorferi infection. The members of the B.
burgdorferi sensu lato group, which includes B. burgdorferi sensu stricto, B. garinii and
B. afzelii, have evolved a variety of mechanisms enabling them to escape complementmediated lysis, including the expression of complement regulator-acquiring surface
proteins (CRASPs) and OspE-related proteins (ERPs), which serve as binding sites for
the complement inhibitor factor H and factor H-like protein 1 (FHL-1) (59, 73, 74) The
interacti0on of factor H with these proteins recruits a protease (factor I) that cleaves and
inactivates the complement serum proteins, C3b and C4b. Cleavage of these two
complement proteins prevents the deposition of downstream components onto the surface
of the spirochete; thereby, halting the formation of the membrane attack complex. B.
burgdorferi also express a CD59-like molecule on the outer membrane, which can
inactivate MAC and prevent complement-mediated lysis (109). It has been speculated
that most borreliae are able to evade complement-mediated lysis, and recently a novel
6

protein expressed by B. hermsii (a relapsing fever spirochete) has been discovered which
affords protection to spirochete by inactivating C3b (61). However, iC3b serves as a
ligand for the complement receptor CR3, which mediates the internalization of iC3bopsonized pathogens. Thus, although the expression of CRASP-1 could circumvent
MAC-mediated killing, it could also generate iC3b in close proximity to the spirochete
resulting in CR3-mediated uptake and subsequent phagocytic destruction. The relative
contribution between these two modes of complement-mediated killing during Lyme
pathogenesis is not clear. Because B. burgdorferi express CRASPs, we hypothesize that
CR3-mediated uptake of iC3b opsonized spirochetes would represent an important
mechanism of bacterial clearance, especially during the initial deposition of the bacterium
in the skin, which occurs during the bloodmeal and also during the dissemination of the
spirochete through the mammalian circulation. Moreover,

During the acquisition of the blood meal and transmission of the spirochete, the
tick hypostome punctures the host dermis activating the host's hemostatic and innate
immune defenses resulting the recruitment of innate immune cells including neutrophils
and macrophages, among other cell types (135). One way B. burgdorferi overcomes this
cellular challenge is by usurping tick salivary proteins that are potent suppressors of the
host defense mechanisms, including neutrophil, macrophage, B cell and T cell activation
(4, 38, 51, 57, 70, 71, 78, 111, 112, 131-133).

Lyme disease pathogenesis

Following deposition into the dermis and successful colonization, the highly
motile B. burgdorferi establishes local infection (Stage I, Lyme disease). This is marked
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by the appearance of a slowly expanding skin lesion called erythema migrans (EM),
which forms at the site of the tick bite 70 to 80 percent of the time and may take between
3 and 32 days to appear (122, 126). In the United States, other symptoms that may appear
at this stage include fever, headache, malaise, myalgia and/or arthralgia and clinical signs
that suggest spirochete dissemination (125).

The spirochete then disseminates throughout the body by binding to blood
components, including plasminogen and its activators, activated platelets and integrins
lining the endothelium of blood vessels (Stage II, Lyme disease) (30-32). Symptoms of
stage II can include conduction system abnormalities, meningitis, and acute arthritis,
which appear in 60% of untreated individuals in the United States (124). Some untreated
individuals develop stage III Lyme disease, which is generally characterized by
prolonged infection with the spirochete. Late stage symptoms may include chronic
arthritis, neuroborreliosis, or cutaneous lesions such as acrodermatitis chronica
atrophicans.

Clinical presentations of Lyme disease are the result of local inflammatory
reactions to the spirochete. Consequently, B. burgdorferi is the subject of intensive
investigation in order to elucidate the mechanisms that contribute to its ability to cause
persistent infection and multi-system disease, despite the development of strong immune
responses. The control of the number of bacteria in the mammalian host likely depends
on several immune effector mechanisms, such as the development of antibody responses
and the capacity of phagocytic cells to clear spirochetes.
Murine models of Lyme disease
8

Among the inflammatory conditions observed in infected humans, Lyme arthritis
and carditis are reproduced to some extent in the murine model of infection with the
spirochete (7). Mice become persistently infected upon experimental infection and
develop joint and cardiac inflammation that resembles the human disease (6). The
incidence and severity of murine Lyme borreliosis is dependent on the genetic
background of the infected animals. Thus, C3H mice develop Lyme carditis and arthritis
with a greater incidence and severity than strains such as DBA/2, B6 or 129 (6, 22, 141).
As a result, we prefer to use the B6 model of B. burgdorferi infection, because the
modulatory affects of specific cell types are not constrained by the high degree of
inflammation observed in highly susceptible mouse strains, such as C3H. The basis for
the genetic susceptibility to the development of Lyme inflammation is unknown. Among
the differences among diverse inbred strains of mice, a notable factor that can influence
the response to infection and the outcome of infectious inflammation is the capacity of
iNKT cells to respond to specific ligands. Thus, recent reports have demonstrated that
iNKT cells from B6 mice respond more vigorously and with faster kinetics than those
from other strains, including BALB/c and C3H (116). These results make B6 mice an
ideal model to test the response of iNKT cells in the context of murine infection.
T cell activation during experimental Lyme borreliosis
The T cell-derived cytokine, IFNγ, has been shown to enhance cellular responses
to various pathogens, most notably intracellular pathogens, including viruses, bacteria
and parasites. Reports have suggested that an intact IFNγ response is important for
controlling the pathogenesis of Lyme carditis but not Lyme arthritis (16, 20, 22, 52). This
is an interesting observation given that B. burgdorferi is an extracellular spirochete.
9

Although the presence of T cells in the absence of B cells results in the exacerbation of
Lyme carditis (94), mice lacking T cells failed to resolve cardiac inflammation at 60 days
of infection (93) and CD4+ T cells have been shown to mediate the regression of murine
Lyme carditis 45 days after infection (16). The contribution of invariant NKT cells to
these responses has until now not been determined.
Invariant Natural Killer T cell activation
Natural Killer T (NKT) cells are a unique and complex population of T
lymphocytes that co-express αβ T cell (TCR) and NK receptors (53, 75). In humans,
NKT cells nearly always have a Vα24-Jα18 TCR (75), whereas mouse NKT cells
possess a Vα14-Jα18 rearrangement. In both humans and mice, this invariant TCR is
capable of antigen recognition in the context of an MHC class I-like molecule, CD1d,
which is adapted for the presentation of lipid antigens (130). Experimental infection of
B6/129 mice deficient in CD1d with B. burgdorferi revealed that CD1d has an important
role in controlling spirochete burdens as well as Lyme arthritis (76). Although CD1ddeficient mice lack Vα14-Jα18i NKT cells because of a developmental failure in the
thymus, they also lack other CD1d-reactive T cells with more diverse TCRs (26, 27, 76)
and further show deficient marginal zone B cell responses, which are involved in the
response to B. burgdorferi (10, 11). This pleiotropy complicates the assignment of the
observed phenotype to a single cell type, such as iNKT cells. In contrast, Jα18-deficent
mice specifically lack Vα14-Jα18i NKT cells and thus represent a suitable model to
determine the role of iNKT cells in the pathogenesis of Lyme disease. Upon activation,
Vα14-Jα18i NKT cells rapidly produce large quantities of cytokines such as IFNγ, IL-4,
IL-17, IL-5 and IL-13, which can modulate many immunological processes, including
10

tumor immunity, maintenance of self-tolerance, prevention of autoimmune disorders and
protection from a variety of pathogens during experimental infections (75, 96).
Pathogenic bacteria can also activate Vα14-Jα18i NKT cells indirectly through Toll-like
receptor (TLR) 4, 7 or 9-driven maturation of dendritic cells, which then present selfglycolipids in the context of CD1d and soluble factors such as IL-12 or type 1 interferon
(19, 92). Until recently, the identification of an iNKT cell antigen expressed by a human
pathogen capable of directly activating iNKT cells eluded investigators. Kinjo and coworkers reported that the Lyme disease spirochete Borrelia burgdorferi expresses a
diacylglycerol glycolipid, BbGL-IIc, which acts as a natural antigen for murine and
human iNKT cells (68). To date B. burgdorferi is the only known human pathogen
containing an antigen capable of activating iNKT cells.
Antibody responses during Lyme borreliosis
Prior to the development of an antibody-specific immune response, the degree of
clearance by circulating phagocytes is very limited, indicating that the humoral response
to B. burgdorferi might be necessary for resolution of spirochetal infection. Plasma cells
are the principal effector cells involved in the humoral response, and antibodies are
specific and powerful effector molecules of the adaptive immune response. Once
antibodies bind to their specific foreign antigen, they confer protection to the host using a
variety of effector mechanisms. In general, antibodies contribute to adaptive immunity by
neutralizing microbes or their products, activation of complement, and opsonization,
which leads to phagocytosis of microorganisms. The activation of B cells and their
differentiation into antibody secreting plasma cells often requires an interaction with
helper T cells, which controls isotype switching as well as somatic hypermutation.
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However, in response to B. burgdorferi, T cell independent humoral responses also
confer protection to the host. T cell independent humoral immune responses are critical
for resolving symptoms associated with B. burgdorferi infection (93). T cell deficient
mice infected with B. burgdorferi mount a protective antibody response, which upon
passive serum transfer affords protection to severe combined immune deficient (SCID)
mice from homologous challenge (93, 118). However, mice that lack both B and T cells
developed severe arthritis and carditis in response to infection with B. burgdorferi (94).

Stimulation of CD40L, which interacts with CD40 on T cells, is crucial for T cell
dependent activation of B cells and subsequent antibody production. Mice deficient for
CD40L are also able to generate protective antibody responses against B. burgdorferi and
therefore resolve infection (43). Additionally, Class II MHC deficient mice are able to
resolve symptoms associated with B. burgdorferi infection (42). Thus, it is implied that
B. burgdorferi antigens have the ability to stimulate B cells, to expand clonally, and to
differentiate into antibody producing plasma cells, and that T cell independent humoral
responses are extremely important for the protective immunity against B. burgdorferi.

The importance of antibodies in controlling B. burgdorferi infection was
underscored by the discovery of complement-independent bactericidal antibodies, which
have the capacity to control an infection. An IgG1k monoclonal antibody termed CB2
binds to B. burgdorferi-OspB via a single lysine residue causing an alteration in the
structure of OspB; thereby, increasing its susceptibility to protease degradation, and
ultimately leading to the lysis of the spirochete (41). Another bactericidal antibody,
H6831, with identical specificity to OspB was reported. Both CB2 and H6831 are so
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effective at killing B. burgdorferi that their selective pressure on the growth of B.
burgdorferi was used to generate escape mutants of B. burgdorferi that lacked the lysine
necessary for antibody binding to OspB, which made the escape mutants less infectious
(34).
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Table 1.1. Pathogenic versus non-pathogenic B. burgdorferi and their respective tick
vectors and geographic distribution.
B. burgdorferi sensu lato is comprised of the three genospecies of B. burgdorferi
that cause human Lyme disease. In addition to these, eight species of Borrelia have been
identified which are non- or minimally pathogenic. B. burgdorferi sensu stricto is the
causative agent of Lyme disease in North America.
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Figure 1.1. Feeding periods of Ixodes scapularis during the immature and adult
stages of its life.
Larval I. scapularis ticks feed during the late summer and then molt into a
nymphal tick, which feeds the following year during late spring or early summer. Larval
and nymphal I. scapularis ticks feed on certain rodents, including the white-footed mouse
and chipmunk. During late spring or early summer rodents are infected with B.
burgdorferi by infected nymphs, and in the late summer, larvae acquire B. burgdorferi
from the infected rodents. Adult I. scapularis feed on large mammals during the fall, and
in particular, the white-tailed deer, and then lay eggs which persist through the winter and
spring and hatch the following summer. Although the white-tailed deer is not directly
involved in the enzootic life cycle of B. burgdorferi, it is required for survival of I.
scapularis.
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Figure 1.2. The morphological characteristics and structure of B. burgdorferi.
(A) Borrelia burgdorferi is approximately 0.2 to 0.3 µm by 20 to 30 µm, and (B)
is a vigorously motile bacterium due to the presence of periplasmic flagella, which run
lengthwise between the peptidoglycan layer and the outer membrane and originate from
either end of the spirochete where they are anchored to the cytoplasmic membrane and
wind around the protoplasmic cylinder. The presence of flagella also gives B. burgdorferi
its distinctive corkscrew shaped morphology and may be important in the invasiveness of
the spirochete into target tissues and organs.
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Materials and Methods
Mice and infection with B. burgdorferi
Jα18-deficient mice (36) were bred at UMass Amherst. The mice have been
backcrossed to the C57Bl/6 (B6) background more than 10 generations. Age-matched B6
mice were purchased from Jackson laboratories. IFNγRα-deficient mice in a 129 Sv/J
background were purchased from Jackson laboratories and bred at UMass Amherst. Six
to 8 week old mice were infected by subcutaneous injection with 105 B. burgdorferi
strain 297 in the midline of the back, as previously described (58). At 2 weeks of
infection, which represents the acute phase of disease, the mice were sacrificed and
analyzed for inflammation and bacterial burdens, as previously described (100). Arthritis
and carditis were evaluated histologically in formalin-fixed sections processed for H&E
staining. The joints were also decalcified. The hearts were cut in half through bisections
across the atria and ventricles prior to sectioning. Signs of arthritis were evaluated as
described (100), based on a combined assessment of histological parameters of B.
burgdorferi-induced inflammation, such as exudation of fibrin and inflammatory cells
into the joints, alteration in the thickness of tendons or ligament sheaths, as well as
hypertrophy and hyperplasia of the synovium. Signs of carditis were evaluated based on
the cardiac inflammatory infiltrate, including the infiltration of connective tissue with
macrophages at the base of the heart, including surrounding the aortic valve and the atria.
Carditis was scored on a scale of 0 (no inflammation), 1 (mild inflammation with less
than two small foci of infiltration), 2 (moderate inflammation with 2 or more foci of
infiltration), or 3 (severe inflammation with focal and diffuse infiltration covering a large
area). Both joint and heart tissue sections were blindly examined. The Institutional
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Animal Care and Use Committee at UMass Amherst approved all procedures involving
animals.
Cells and stimulations
Mouse bone marrow cells were collected from the femoral shafts by flushing 3
times with 1 ml of cold RPMI (10% FCS and 1% penicillin/streptomycin) supplemented
with 20% L929-conditioned RPMI. The cell suspensions were cultured in 100mm x
15mm petri dishes (Fisher Scientific) in 20% L929-conditioned RPMI for 8 days at 37º C
with 5% CO2. Following incubation, non-adherent cells were eliminated and adherent
macrophages scraped, counted and resuspended in serum-free RPMI medium without
antibiotics prior to use. RAW264.7 macrophages were cultured in RPMI but washed and
resuspended in serum- and antibiotic-free RPMI before use. 106 BMMs or RAW264.7
cells per ml were incubated with recombinant murine IFNγ (rmIFNγ; carrier- and
endotoxin-free; eBioscience, Inc., San Diego, CA) (0, 0.5, 5, 50 ng ml-1) for 12h and
analyzed for expression of CD1d (PE-anti-mouse CD1d, eBioscience, Inc.) or stimulated
with live B. burgdorferi (strain 297) at a 25:1 multiplicity of infection (m.o.i) for 12h.
Following stimulation with B. burgdorferi, culture supernatants were analyzed by ELISA
for TNFα and IL-6, as previously described (103).
B. burgdorferi-specific antibodies
Analysis of total IgG and IgM were determined by coating 96 well plates with 0.5
µg/ml (IgG) or 1.0 µg/ml (IgM) of a B. burgdorferi strain 297 lysate and incubated with
serial two-fold dilutions starting at 1:100 followed by incubation with HRP-conjugated
anti mouse IgM or IgG (BD Pharmingen) (1:10000 dilution). The reactions were
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developed using 1-component TMB substrate and stopped with TMB stop solution (KPL,
Inc., Gaithersburg, MD).

Quantitative analysis of IFNγ expression
The relative expression of IFNγ in cardiac tissue was determined using total RNA
extracted from the base of the heart using the TRIzol reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer's instructions. The RNA was treated with DNase I
(Promega, Madison, WI), and reverse transcribed using random primers (Invitrogen) and
SuperScript II reverse transcriptase (RT) (Invitrogen). The cDNA was amplified using
primers specific for glyceraldehyde 3-phosphate dehydrogenase (gadph; 5’-CCA TCA
CCA TCT TCC AGG AGC GAG-3’ and 5’-CAC AGT CTT CTG GGT GGC AGT GAT
-3’) and ifnγ ( (5’-GCG TCA TTG AAT CAC ACC-3’ and 5’-GGA CCT GTG GGT
TGT TGA CC-3’) in an Mx3005P® QPCR System (Stratagene, La Jolla, CA) and SYBR
green-containing reaction buffer (Roche, Nutley, NJ). Relative expression of the gene is
referred to control-infected mouse heart tissue, as described (65).
Detection of invariant NKT cells
DNA from the hearts of control and infected mice were utilized to perform a
nested-PCR reaction using primers specific for the Vα14-Jα18i TCR. For the first
reaction, non-specific TCR (5'-GTC CTC AGT CCC TGG TTG TC-3' and 5'-CTG CCT
CCG AGG TAG TGA C-3') was amplified using 5 µl of DNA in a total volume of 50 µl
with the following conditions: 94ºC 2 min, (94ºC 1 min, 55ºC 1.5 min, 72ºC 1.5 min) x
30 and 72ºC 2 min. A second reaction using primers specific for the Vα14-Jα18i TCR
(5'-GAC AGT CCT GGT TGA CC-3' and 5'-AAT GCA GCC TCC CTA AG-3’) was
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performed using 5 µl of template from reaction 1 with the same conditions, except that 35
cycles were used.
Confocal Microscopy
At sacrifice, hearts were collected and snap-frozen in O.C.T. freezing medium
(Sigma) and stored at -80ºC. Hearts were grossly cut through the ventricles parallel to the
atria, sectioned using a Triangle Biomedical Sciences Cryostat (Durham, NC) and every
sixth 10 micron section through the aortic sinus was placed on Fisherbrand Superfrost
microscope slides (Fisher Scientific, Pittsburgh, PA). Sections were fixed in -20 ºC
acetone for 5 min, rehydrated in distilled water for 3 min, blocked with Fc Block (antimouse CD16/32, clone 2.4G2; BD Pharmingen, Franklin Lakes, NJ) and stained with the
following monoclonal antibodies: Alexa Fluor488 anti-mouse CD3 (clone 145-2C11),
Alexa Fluor647 anti-mouse CD11b (clone M1/70), PE-anti-mouse CD1d (clone 1B1; BD
Pharmingen). Nuclear staining was done with DAPI (Roche). The sections were imaged
using a Zeiss LSM 510 META confocal laser scanning microscope (Zeiss Microimaging,
Thornwood NY) operating in the multitrack mode, as described before (62).
Analysis of phagocytosis
BMM or RAW264.7 cells were activated with different doses of rmIFNγ for 12
hour in serum- and antibiotic-free RPMI prior to the addition of GFP-expressing B.
burgdorferi strain 297 at an m.o.i. of 10 for 4h. To distinguish between binding and
internalization of spirochetes, the mixtures were incubated at 4 °C and 37 °C, in parallel.
The incubation at 4 °C results in the binding of particles, but not their internalization
(15). After the incubation, the cells were washed and analyzed by flow cytometry. For
Apotome epifluorescence analysis of phagocytosis, RAW264.7 cells were activated with
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50 ng ml-1 of rmIFNγ and challenged with GFP-B. burgdorferi at 37º C, as described. The
cells were then washed, cytospun and stained with the macrophage cell membrane
marker F4/80 (clone BM8; rat anti-mouse F4/80, eBioscience, Inc.) followed by a
secondary stain with Alexa Fluor594 goat anti-rat IgG (Invitrogen).
Statistical analysis
The results are presented as means ± SE. Significant differences between means
were calculated with the Student’s t test. P values of 0.05 or less were considered
statistically significant.
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Results and Discussion
Vα14-Jα18i NKT cells modulate the pathogenesis of Lyme carditis
The identification of B. burgdorferi-derived diacylglycerol glycolipids as natural
antigens to Vα14- and Vα24i- NKT cells (68), prompted us to examine the role of Vα14Jα18i NKT cells in the pathogenesis of Lyme disease. To determine whether Vα14-Jα18i
NKT cells contribute to the host response to B. burgdorferi, we syringe-infected wild
type and Jα18-deficient C57Bl/6 mice with 105 spirochetes in the midline of the back and
allowed infection to progress for 2-3 weeks, which represents the acute phase of infection
(100). Histological evaluation of the joints and hearts of the infected mice revealed that
Jα18-deficient animals are more susceptible to both arthritis (Figure 1.3A) and carditis
(Figures 1.3B and C). Although there was a trend towards worse arthritis in mice that
lacked Jα18, the difference was not significant (Student t test; p = 0.07; n = 15). In
contrast, carditis severity in Jα18-deficient mice was significantly increased (p < 0.01).
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Figure 1.3. Jα18-deficiency results in increased carditis during infection with B.
burgdorferi.
Joint (A) and cardiac (B) inflammation in wild type and Jα18-deficient mice 2
weeks following syringe infection with B. burgdorferi. Data are representative of 2 to 3
experiments with 5 mice per group. (C) Representative H&E-stained cardiac sections
from uninfected, and infected wild type and Jα18-deficient mice.
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Infection of Jα18-deficient mice results in increased spirochetal burdens in the
heart
Inflammation during experimental infection with B. burgdorferi is dependent on
the ability of the spirochete to persist in cardiac and joint tissue (141). Thus, we evaluated
the ability of the mice to clear B. burgdorferi in the absence of Vα14-Jα18i NKT cells by
assessing bacterial loads in the heart tissue of the infected animals, where the differences
in inflammation are more evident as a result of the absence of iNKT cells. Compared to
wild type mice, Jα18-deficient mice harbored more B. burgdorferi in their heart, while
the bacterial burden in the ear was unaffected by the loss of Vα14-Jα18i NKT cells
(Figure 1.4). Vα14-Jα18i NKT cells have been shown to potentiate the antibody response
to various pathogens (46, 79). Since the antibody response to B. burgdorferi is critical to
clear spirochetal infection (34), we assessed the B. burgdorferi-specific IgM and IgG
responses 2 weeks following infection. The sera levels of antigen-specific IgM and IgG
in wild type and Jα18-deficient mice were similar (Figures 1.5A and B) as well as IgG
antigen specificity as determined by Western blot (Figure 1.5C).
Moreover, studies have demonstrated that iNKT cells can promote naïve CD4+ T
cell (Th0) polarization towards a Th1 or Th2 effector phenotype, depending on the
infectious agent (130). For example, iNKT cells enhance Chlamydia trachomatis
infection through augmentation of the Th2 response (14). The mechanism behind iNKTdirected T helper cell polarization has not been defined; however, it is intriguing to
speculate that the early production of IFNγ by iNKT cells during infection with B.
burgdorferi can promote differentiation of Th0 cells toward the Th1 phenotype by
inducing IL-12 production. We therefore determined the contribution of iNKT cells to
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Th1 differentiation during infection with B. burgdorferi. Restimulation of Jα18-deficient
splenocytes, obtained from infected mice, with B. burgdorferi did not result in
diminished levels of IFNγ, compared to wildtype controls (Figure 1.6).
These results demonstrate an important role for Vα14-Jα18i NKT cells in the
control of B. burgdorferi at the tissue -rather than at the systemic- level where acute
inflammation occur, and that the differences in B. burgdorferi control and pathology
between the Jα18-deficient and wildtype mice are not due to distinct antibody responses
or altered T cell polarization.
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Figure 1.4. Jα18-deficient mice harbor increased bacterial burdens in the hearts
during B. burgdorferi infection.
Quantitative real-time PCR determination of spirochete burden in the ears and
heart of infected wild type (n=13 and n=8, respectively) and Jα18-deficient mice (n=14
and n=5, respectively) 2 weeks following infection in 2 separate experiments.
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Figure 1.5. Jα18-deficient mice have a normal IgM and IgG response following B.
burgdorferi infection.
Serum ELISA titers for total IgM (A) or IgG (B) from 2-week infected wild type
and Jα18-deficient mice. Results depicted were derived from 2 uninfected mice and 7-15
mice per infected group and are representative of at least 2 independent experiments. (C)
Immunoblot for total IgG from wildtype and Ja18-deficient mice 2-weeks post infection
with B. burgdorferi. Numbers correspond to individual mice.
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Figure 1.6. Vα14-Jα18i NKT cell-derived IFNγ does not impair normal Th1
polarization during infection with B. burgdorferi.
ELISA analysis of IFNγ following B. burgdorferi-specific restimulation of whole
splenocytes obtained from wildtype or Jα18-deficient mice. Results depicted were
derived from 3 wildtype mice and 7 Jα18-deficient mice per group.
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Vα14-Jα18i NKT cells and CD1d-positive macrophages migrate to the inflamed
heart of B. burgdorferi-infected mice
Vα14-Jα18i NKT cells have been shown to migrate to sites of inflammation in
the lung, liver and spleen (1, 86, 95, 101). We therefore analyzed the presence of Vα14Jα18i NKT cells in the hearts of uninfected and B. burgdorferi-infected mice using a
nested PCR approach (37, 117). While control mice did not harbor Vα14-Jα18i NKT
cells in the heart, the presence of the invariant TCR alpha chain was readily detected in
the inflamed cardiac tissue of wild type, but not Jα18-deficient mice (Figure 1.7A). We
also analyzed by confocal microscopy the hearts of the infected mice for the presence of
CD1d, as a potential contributor to the activation of iNKT cells. The infected hearts
contained, as expected, CD11b-and CD3-expressing lymphocytes, (Figure 1.7B), and
confirmed (115) a predominant macrophage infiltration during Lyme carditis. The
inflamed hearts also showed increased expression of CD1d compared to uninfected
controls (Figure 1.7B). Because CD1d expression is a requirement of APC-mediated
activation of iNKT cells, we determined the identity of the iNKT cell activator in the
inflamed heart. Confocal analysis revealed that CD1d expression colocalized with CD11b
expression (Figure 1.7C). The presence of CD1d in the inflamed hearts indicates the
potential for the direct activation of Vα14-Jα18i NKT cells through presentation of B.
burgdorferi glycolipids. Taken together, the appearance of iNKT cells in a B. burgdorferi
colonized organ competent in iNKT antigen presentation, which presents with
exacerbated disease and increased bacterial burden in the absence of iNKT cells, is
indicative of an important role for this cell type in protection against murine Lyme
carditis.
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Figure 1.7. Vα14-Jα18i NKT cells and CD1d positive macrophages migrate to the
inflamed heart during infection with B. burgdorferi.
(A) Nested PCR was used to detect the presence of the Vα14-Jα18i TCR in the inflamed
heart of wild-type infected mice. gapdh amplification was used to verify the presence of
DNA. The data are derived from 2 control mice and 3 mice per infected group. (B)
Confocal microscopy analysis of heart sections of control or infected B6 mice to
determine the presence of CD1d+ (red), CD11b+ (purple) and CD3+ cells (green). Nuclei
were stained with DAPI. Results depicted here are representative of 2 experiments. (C)
Confocal microscopy of a B. burgdorferi-infected heart showing the presence of CD11b+
(green) cells and their co-localization with CD1d (red) staining. The panel on the right
shows co-localization of both signals.
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Vα14-Jα18 iNKT cells are responsible for the production of IFNγ in the infected
heart

B. burgdorferi glycolipid-pulsed dendritic cells induce IFNγ production by Vα14Jα18i NKT cells in vivo (68). In addition, IFNγ-producing CD4+ T cells facilitate the
regression of murine Lyme carditis (16), while Stat1-deficient mice infected with B.
burgdorferi develop exacerbated Lyme carditis, compared to control mice (20). We
therefore addressed the contribution of Vα14-Jα18i NKT cells to the pool of cardiac
IFNγ in B. burgdorferi-infected mice. B. burgdorferi infection of wild type mice resulted
in increased expression of the ifnγ gene in the cardiac tissue compared to uninfected
controls, as determined by quantitative RT-PCR (Figure 1.8). However, the level of ifnγ
gene expression in the hearts of B. burgdorferi-infected mice was reduced in Jα18deficient mice at the peak of disease (Student’s t test, p < .05; Figure 1.8). These results
indicate that Vα14-Jα18i NKT cells are critical for generating an IFNγ response in the
heart, which might play a role in the pathogenesis of Lyme carditis.

We next tested the direct contribution of IFNγ to the pathogenesis of Lyme
carditis by infecting IFNγ receptor alpha (IFNγRα)-deficient 129S mice. Like Jα18deficient mice, IFNγRα-deficient mice developed increased cardiac inflammation
following syringe infection with B. burgdorferi (Student t test; p < .05; Figure 1.9A),
supporting a role for IFNγ in the protection against Lyme carditis. The quantification of
B. burgdorferi burdens by real-time PCR in the heart of the infected mice showed a
significant (p < .006) increase in the levels of bacteria in the absence of IFNγ-mediated
signals (Figure 1.9B), indicating that IFNγ contributes to the control of bacterial burdens
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during infection. Overall, these data indicate that Vα14-Jα18i NKT-derived IFNγ
mediates protection against cardiac inflammation during infection with B. burgdorferi.
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Figure 1.8. Vα14-Jα18i NKT cells regulate the expression of IFNγ in B. burgdorferiinfected hearts.
Relative IFNγ mRNA expression in the heart by real-time RT-PCR. Hearts were
removed from 2-week B. burgdorferi-infected wildtype or Jα18-deficient C57Bl/6 mice.
Results are the average of 3 mice per group.

33

Figure 1.9. IFNγ mediates protection against Lyme carditis and facilitates clearance
of B. burgdorferi from the heart.
(A) Increased cardiac inflammation in IFNγRα-deficient mice at 2 weeks of
infection with B. burgdorferi, compared to wild type mice. Results are derived from 2
independent experiments. (B) Bacterial burdens in the heart of wild type (n=5) and
IFNγRα-deficient, infected mice at 2 weeks of infection. * Student’s T test, p<0.006.
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IFNγ signaling enhances macrophage responses to B. burgdorferi
The mechanism underlying the control of cardiac inflammation during murine
Lyme borreliosis by IFNγ has not been elucidated. IFNγ enhances cellular responses,
including macrophages, to various pathogens (17). Indeed, activation of bone marrowderived macrophages (BMMs) with IFNγ enhances spirochete recognition, as evidenced
by augmented TNFα and IL-6 production elicited against live B. burgdorferi (Figures
1.10A and B). Increased B. burgdorferi burdens in the heart of IFNγRα-deficient and
Jα18-deficient mice during the presence of a strong antibody response suggested a defect
in phagocytic clearance of the spirochete by infiltrating macrophages. We therefore
defined the contribution of IFNγ to macrophage-mediated clearance of B. burgdorferi by
phagocytosis. First, we determined by flow cytometric analysis that BMMs readily
phagocytose GFP-expressing infectious B. burgdorferi (Figure 1.10C). Activation with
recombinant murine IFNγ increased the already high phagocytic capacity of BMMs for B.
burgdorferi (Figure 1.10C). We also performed this assay using the macrophage cell line
RAW264.7. Incubation of RAW264.7 cells with GFP-B. burgdorferi resulted in a modest
amount of phagocytosis, compared to BMMs, confirming previous reports indicating
their relatively low phagocytic capacity (39). The activation of these cells with IFNγ
markedly enhanced the percentage of cells that had internalized GFP-expressing B.
burgdorferi, as determined by flow cytometric analysis and flourescence microscopy
(Figures 1.10D and E). These results suggested that iNKT cells control the levels of
spirochetes in the infected heart through the production of IFNγ and increased
phagocytosis.
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Figure 1.10. IFNγ enhances the effector function of macrophages responding to B.
burgdorferi.
(A) rmIFNγ activation (0, 0.5, 5, 50 ng/ml) of BMMs for 16 h leads to enhanced
production of TNFα (A) and IL-6 (B) in response to live B. burgdorferi. (C) BMMs were
stimulated with (green histogram) or without (black histogram) 50 ng/ml of rmIFNγ for
16 h. The cells were washed and assessed their phagocytic capacity for GFP-B.
burgdorferi at an m.o.i of 25:1. (D) RAW264.7 cells were stimulated with 50 ng/ml of
rmIFNγ for 16 h and assessed their phagocytic capacity, as before. (E) The cells were
also cytospun in positively charged slides, stained for the macrophage surface marker
F4/80 (red) and the nucleus (blue) and analyzed by fluorescence microscopy (ApoTome)
for B. burgdorferi phagocytosis. Results are representative of at least 3 experiments.
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IFNγ enhances the surface expression of CD1d in macrophages
Previous reports have suggested that IFNγ can increase CD1d surface expression
by macrophages (75). We thus assessed the effect of IFNγ on the expression of CD1d in
primary macrophages and RAW264.7 cells. We stimulated BMMs (Figure 2.9A) and
RAW264.7 cells (Figure 1.11B) with 50 ng ml-1 of recombinant IFNγ for 16 h. The cells
were subsequently assessed for surface CD1d expression by flow cytometry. IFNγ
treatment increased the expression of CD1d in both BMMs and RAW264.7 cells (Figures
1.11A and B). Since B. burgdorferi induces the upregulation of CD1 molecules on human
monocytes (33), we also assessed the effect of live spirochetes on CD1d expression by
BMMs and RAW264.7 cells. In contrast to human monocytes, the stimulation of both
BMMs and RAW264.7 cells with live B. burgdorferi resulted in a minimal increase of
CD1d expression (data not shown). These results suggest that during infection with B.
burgdorferi, Vα14-Jα18i NKT-derived IFNγ is self-renewing through its capacity to
induce CD1d expression and presentation to Vα14-Jα18i NKT cells (Figure 1.12).
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Figure 1.11. IFNγ increases the surface expression of CD1d in macrophages.
BMMs (A) and RAW264.7 cells (B) were stimulated with 50 ng/ml of rmIFNγ
for 16 h (red histogram) or left unstimulated (black histogram). The cells were washed
and stained with an anti-CD1d antibody labeled with phycoerythrin (PE). The grey
histogram represents unlabeled cells. Results are representative of at least 2 experiments
for each cell type.

38

Figure 1.12. Proposed model of iNKT cell activation in the heart during Lyme
borreliosis.
Macrophages phagocytose invading B. burgdorferi and present antigen in the
context of CD1d to local Vα14-Jα18 iNKT cells resulting in the production of IFNγ.
IFNγ activation of macrophages results in enhanced phagocytosis of B. burgdorferi and
upregulation of CD1d. These events further perpetuate iNKT cell activation and thus
results in self-renewal of IFNγ.
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CHAPTER II
COMPLEMENT RECEPTOR 3 MEDIATES THE PHAGOCYTOSIS OF B.
BURGDORFERI AND NEGATIVELY REGULATES PROINFLAMMATORY
CYTOKINE INDUCTION
Introduction
The recognition of pathogenic bacteria or their constituents by pattern recognition
receptors (PRRs) on the surface of innate immune cells is critical for the induction of an
effective immune response. In addition to regulating cytokine secretion, nitric oxide
production and cell maturation, engagement of these receptors can trigger phagocytosis
of microbes and also orchestrate adaptive immunity. The Toll-like receptors (TLRs) 1
and 2 function as PRRs for B. burgdorferi lipoproteins (2, 85), including the prototypical
borrelial lipoprotein, OspA. Studies using the murine model of Lyme disease have shown
that TLRs 1 and 2, as well as the TLR adaptor protein, MyD88, are important for
controlling the expansion of B. burgdorferi in target organs and tissues (8, 18, 87, 137,
138). Thus, it is well established that TLRs, their adaptor proteins or their co-receptors,
such as CD14, are important in the recognition of B. burgdorferi (120, 138), but in
regards to the identification of other PRRs involved in B. burgdorferi recognition, not
much progress has been made. Moreover, although TLR signaling might control
phagocytosis of B. burgdorferi to some extent (121), the identification of a bonafide
receptor involved in spirochete phagocytosis has eluded investigators.

Of particular interest are the β2 integrins, which include LFA-1 (CD11a/CD18),
CR3 (CD11b/CD18) and CR4 (CD11c/CD18), because it was reported that reduced
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expression of the common beta chain, CD18, results in exacerbated Lyme carditis during
experimental infection with B. burgdorferi (55). Furthemore, CR3 and CR4 have been
shown to participate in the recognition and phagocytosis of a number of pathogens,
including Bacillus anthracis spores (102), Neisseria meningitidis (66), Bordetella
pertussis (98) Francisella tularensis (12) and serum opsonized B. burgdorferi (29). The
importance of β2 integrin-mediated immunoprotection is highlighted in patients suffering
from leukocyte adhesion deficiency-1 (LAD-1) syndrome who suffer from severe
symptoms, including defects in phagocytosis and recurrent infections. In these patients,
mutations in CD18 result in little or no expression of LFA-1, CR3 or CR4 (60).

In this study, we determine the role of CR3 in mediating phagocytosis of the
Lyme disease spirochete B. burgdorferi and the production of proinflammatory
cytokines.

Innate immune responses to B. burgdorferi

The recognition of pathogens or their constituents by cells of the innate immune
system constitutes the ‘first line’ of host defense. The detection of conserved bacterial
motifs, known as pathogen associated molecular patterns (PAMPs) initiates a cascade of
responses that lead to the upregulation of chemokines and cytokines, adhesion molecules
and a vast array of other effector molecules. These events are aimed at the recruitment of
phagocytic cells, their activation and the eventual development of the adaptive immune
response and depend on the presence of germline-encoded PRRs. These pattern
recognition molecules are being extensively studied because they not only mediate the
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initial response to microorganisms, but they also modulate the extent and quality of
acquired immune response. Toll-like receptors (TLRs), identified as the mammalian
counterparts of the Toll protein in Drosophila that mediates the immune response to
fungi and Gram-positive bacteria are the most studied, but do not constitute the only
mechanism by which innate immune cells recognize infecting microorganisms. C-type
lectins, Scavenger receptors, integrins and Nod-like receptors are also PRR that are
uniquely suited to recognize specific structures that are present in a group or groups of
microorganisms and that distinguishes them from the more specific recognition of
antigens by the T and B cell receptors. The main sentinel cells of innate immunity
(epithelial, phagocytic and dendritic cells) express unique combinations of PRRs, which
likely result in tissue-specific responses to pathogen (64). It is the stimulation of complex
sets of pattern recognition receptors that induce an effective immune response. For
example, cooperative signaling between the C-type lectin, Dectin-1 and TLR2 enhance
the innate response to Candida albicans (47) and Mycobacterium tuberculosis (140),
while cooperation between Mannose Binding Lectin (MBL) and TLR2/6 signaling from
within the phagosome enhance the response to Staphylococcus aureus (63). Thus,
multiple PRRs contribute to defining pathogen-specific innate immune responses.

TLRs collectively recognize conserved lipid, carbohydrate, peptide and nucleicacid structures expressed by different groups of microorganisms. B. burgdorferi does not
contain LPS, in contrast with other members of the spirochete group and therefore, does
not engage TLR4. The most important pattern recognized by innate immune receptors is
constituted by the triacylated outer-surface lipoproteins of the spirochete and this seems
to be true for whole spirochetes and lysates. It is not clear what the specific interaction
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between whole spirochetes and antigens exposed by bacterial lysis with immune cells is
in vivo. However, it is conceivable that both elicit immune responses since B. burdorgferi
is likely to die in vivo, for example in the presence of antibody in a process that does not
required complement or phagocytosis (34, 41, 89).

The interaction of B. burgdorferi lipoproteins with complexes formed by TLRs 1
and 2 on the surface of innate immune and other cell types initiates a series of
incompletely defined signaling cascades that results in the production of proinflammatory
cytokines (IL-1β, TNFα, IL-12, and IL-18, among others), chemokines (IL-8, MCP-1,
KC), metalloproteinases and adhesion molecules (E-selectin, VCAM-1 and ICAM-1)
(56). These proteins mediate the inflammatory response to the spirochete through the
production of proinflammatory cytokines and chemotactic factors that further induce the
recruitment of inflammatory cells. In addition TLR1/2 complexes also modulate adaptive
immune responses, through increased antigen presentation, induction of costimulatory
signals on antigen presenting cells and the production of cytokines that influence CD4+ T
cell differentiation and effector function. Detection of B. burgdorferi lipoprotein is
important for defining the in vivo response to B. burgdorferi, because TLR1-(2), TLR2(137), or MyD88-deficient (18, 87) mice have significant increases in bacterial burden,
compared to wildtype mice. Moreover, the development of arthritis in the absence of
TLRs, CD14 (13) or MyD88 suggests that TLR-independent PRRs exist that trigger the
inflammatory response to the spirochete. So, although innate sensing of the spirochete
has solely been attributed to its recognition by TLR2/1 heterodimer complexes, the TLR
response is likely amplified and further defined by cooperation with additional PRRs,
which may or may not occur within the phagosome. Indeed, the induction of a potentiated
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inflammatory response following phagocytosis of B. burgdorferi, compared to cellsurface stimulation, indicates the existence of additional PRRs involved in the
recognition of B. burgdorferi (35, 99). Whether this augmented response is the result of
cooperative signaling with the phagocytic receptor or other PRRs recruited to the
phagosome is unclear.
Mechanisms of phagocytosis

Phagocytosis is an evolutionary conserved phenomenon whereby large particles
are ingested and destroyed via an extraordinarily complex process involving cognate
receptors that distinguish foreign particles from self. While lower, single-celled
organisms use phagocytosis primarily for the acquisition of nutrients, phagocytosis in
multi-cellular Metazoans is carried out by specialized cells and is critical for the uptake
and degradation of apoptotic cells and infectious agents. The contribution of phagocytosis
to Lyme disease pathogenesis has not been studied, primarily because the mechanisms
involved in this process have yet to be elucidated. Presumably, this cardinal mechanism
of bacterial clearance is necessary for control of B. burgdorferi infection prior to and
following the development of the adaptive immune response.
Phagocytic cells possess several pathways of phagocytic uptake, which vary
depending on the origin of the phagocytic signal. Opsonin-dependent pathways are
mediated by FcR and complement receptors, including complement receptor 3 (CR3,
CD11b/CD18 or Mac-1), which was shown to mediate phagocytosis of non-specifically
opsonized B. burgdorferi by human polymorphonucleocytes. Opsonin-independent
phagocytosis can be mediated by multiple pattern recognition receptors, including C-type
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lectins, scavenger receptors and integrins. Following adherence of the pathogen to the
phagocytic cell through receptor interaction, phagocytic uptake is initiated by F-actin
remodeling. Actin remodeling at the site of attachment is required for all forms of
phagocytosis. The signaling cascade involved in the reorganization of actin is highly
dynamic and can vary depending on which receptor(s) the phagocytic signal emanates
from. Following attachment and actin remodeling, particles are internalized into
phagosomes. It is here that microbial destruction and antigen presentation are initiated,
through subsequent fusions with acid rich vesicles called lysosomes.
Recruitment of phagocytic cells

The recruitment of phagocytic cells into sites of infection precedes the
phagocytosis and destruction of pathogenic organisms. Recruitment is mediated by the
production of chemokines, increased vascular permeability and upregulated expression of
cell adhesion molecules in endothelial cells. B. bugdorferi induces the upregulation of
these factors in different cell types. Chemokine production at sites of pathology in disease
susceptible C3H/HeJ mice and –resistant C57BL/6J mice show that inflammation is
related to increased production of neutrophil and monocyte-macrophage chemokines, KC
and MCP-1, respectively (21). In Lyme disease patients, the production of chemokines,
especially IL-8, during the initial response to B. burgdorferi correlates well with the onset
of symptoms known to occur during the early stages of infection, suggesting that their
production is increased during the beginning of the infection to recruit phagocytic cells,
which are involved in the initial clearance of the spirochete. Overall, these results also
suggest that the chemokine response is modulated once the infection progresses, and that
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progression of the disease may be dependent on the regulation of these chemoattractants
whose production might be altered by the presence of the infiltrating cells.

Complement opsonization

In addition to initiating the alternative pathway of complement activation and
MAC-mediated lysis of microbes, C3b acts as a serum opsonin that enhances the
phagocytic ingestion and destruction of microbes through recognition by Complement
Receptor 1 (CD35) (113). The members of the pathogenic B. burgdorferi sensu lato
group have evolved a variety of mechanisms enabling them to escape complementmediated lysis, including the expression of complement regulator-acquiring surface
proteins (CRASPs), which serve as binding sites for the complement inhibitor factor H
and factor H-like protein 1 (FHL-1) (59, 73, 74). Expression of CRASPs ultimately
results in the cleavage of bound serum complement protein C3b into the serum opsonin
inactivated C3b (iC3b), which is recognized by Complement Receptor 3 (CR3,
CD11b/CD18, Mac-1). Thus, although the spirochete has evolved mechanisms to evade
MAC-mediated lysis through the cleavage of C3b, this very mechanism could also
generate iC3b fragments in close proximity to the B. burgdorferi organism making
complement-mediated phagocytosis through CR3 a particularly relevant form of host
defense against the invading and disseminated spirochete.
Complement Receptor 3
CR3 (CD11b/CD18) is a transmembrane glycoprotein of the β2 integrin family
with multiple substrate specificity that is primarily found on phagocytic cells. The
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multifarious nature of CR3 is borne from its molecular structure, which consists of two
distinct functional domains in the extracellular portion of the CD11b subunit. One such
domain, the inserted domain (I-domain), of CR3 binds iC3b and intercellular adhesion
molecule-1 (ICAM-1), among others, and thus participates in opsonin-mediated
phagocytosis and diapedesis, respectively (114). The other domain, called the lectin-like
domain (LLD), of CR3 mediates binding to several polysaccharide-containing pathogen
associated molecules, such as filamentous hemagglutinin (FHA) of Bordetella pertussis
and zymosan of Saccharomyces cerevisiae, where it participates in the formation of
transmembrane signaling complexes with GPI-anchored glycoproteins resulting in
adhesion, degranulation or phagocytosis (40). In addition, CR3 has been shown to
mediate the phagocytosis of Neisseria meningitidis (66) and Bacillus anthracis spores
(102) by macrophages. Overall, the extensive binding repertoire of CR3 facilitates
intercellular interactions that are important for immunological maintenance of the host.
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Materials and Methods
Mice
C57Bl/6 mice were bred at UMass Amherst. TLR2-deficient and CD11b-deficient
C57Bl/6 mice were purchased from Jackson laboratories. The Institutional Animal Care
and Use Committee at UMass Amherst approved all procedures involving animals.
Cell culture and stimulations
Bone marrow-derived macrophages were generated as described previously (104).
Briefly, bone marrow cells were collected from the femoral shafts of wildtype or CD11bdeficient C57Bl/6 mice and cultured in 20% L929-conditioned RPMI 1640 supplemented
with 10% FCS (Hyclone), 2.4 mM L-glutamine and 10% penicillin-streptomycin
(Invitrogen) in 100mm x 15mm petri dishes (Fisher Scientific) for 8 days at 37º C with
5% CO2. Following incubation, non-adherent cells were eliminated and adherent
macrophages scraped, counted and resuspended in serum-free RPMI medium without
antibiotics overnight prior to use. Where indicated, 106 wildtype, TLR2- or CD11bdeficient BMMs per mL were used for stimulation with different MOIs of live or
sonicated B. burgdorferi in the absence or presence of wildtype or C3-deficient normal
mouse serum (NMS) for 12h. Following stimulation, TNF secretion was determined by
ELISA.
The CHO cells transfected with human CR3 or CR4 were maintained in Ham's F12 medium supplemented with 10% FCS and 10% penicillin-streptomycin. 24 hours prior
to use, the cells were washed and resuspended in FCS- and penicillin-streptomycin-free
Ham's F-12.
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The macrophage-like RAW264.7 cells were maintained in RPMI 1640
supplemented with 10% FCS, 2.4 mM L-glutamine and 10% penicillin-streptomycin, as
described. RAW264.7 cells were washed and resuspended in FCS- and penicillinstreptomycin-free Ham's F-12, 24 hours before use.
Bacteria
GFP-expressing B. burgdorferi was generated by stably inserting a GFP-pflaB
construct into the bbb20-bbb21 intergenic region of the virulent parental strain 297 (clone
CE162). The GFP-expressing B. burgdorferi clone is completely stable even without
antibiotic selection. Furthermore, the strain is comparable in virulence to the parental
strain by needle inoculation and goes through the tick-mouse cycle as efficiently as the
parental strain. A complete characterization of the clone, BB914, has been made and is
the subject of a forthcoming manuscript (Ems et al. in preparation). The bacteria were
cultured in BSK-II (Sigma) medium at 33ºC and used at log phase of growth.
CR3 receptor blocking
Before co-culture of B. burgdorferi with CHO cells or macrophages, cells were
incubated for 15 minutes with 1, 10 or 20 µg ml-1 of rat anti-mouse CD11b clone M1/70
antibodies (BD Pharmingen). For control experiments, cells were preincubated with 10
µg ml-1 of rat anti-mouse CD11a clone M1/74 (BD Pharmingen) or Armenian Hamster
anti-mouse CD11c clone HL3 (BD Pharmingen). Alternatively, cells were cultured in the
presence of .1 or 1mM EDTA (Sigma) during incubation with B. burgdorferi to chelate
divalent cations, including Mg2+, and to block ligand binding to the inserted domain of
CR3.
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Phagocytosis assay
Internalization of B. burgdorferi was determined by a combination of flow
cytometry and fluorescence microscopy. CHO-cells or macrophages (106 ml-1) were
cultured in fetal calf serum-free and antibiotic-free medium with B. burgdorferi in the
absence or presence of 5% normal mouse serum at different MOIs for 6h, except where
indicated. Following incubation of the cells with B. burgdorferi, the cells were washed
extensively and resuspended in PBS supplemented with 10% FCS and analyzed by flow
cytometry or were further prepared for microscopic analysis.
To confirm phagocytosis, cells were examined by fluorescence microscopy.
Following incubation of cells with bacteria, the cells were washed extensively and fixed
in 3.7% para-formaldehyde for 7 minutes and then washed with PBS. The cells were then
permeabilized with 0.1% Triton-X for 5 minutes and washed in PBS. Following blocking
of non-specific binding with 5% BSA for 60 minutes, the permeabilized cells were
stained with rhodamine phalloidin to visualize the actin skeleton for 30 minutes at 37ºC
and DAPI to stain the nuclei (Molecular Probes) for 5 minutes at 37ºC. After extensive
washing in PBS, the cells were mounted with Prolong Gold Anti-fade mounting reagent
(Molecular Probes). Photographs were taken using a Zeiss Axiovert 200M inverted
microscope (Thornwood, NY) equipped with a Hamamatsu Orca camera (Bridgewater,
NJ).
Analysis of CR3 expression
The relative expression of CD18 and CD11b in RAW264.7 cells following
activation of 106 cells with 100 ng/ml rmIFNγ was determined using total RNA extracted
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from harvested cells using the TRIzol reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer's instructions. The RNA was treated with DNase I (Promega, Madison,
WI), and reverse transcribed using random primers (Invitrogen) and SuperScript II
reverse transcriptase (RT) (Invitrogen). The cDNA was amplified using primers specific
for glyceraldehyde 3-phosphate dehydrogenase (gadph; 5’-CCA TCA CCA TCT TCC
AGG AGC GAG-3’ and 5’-CAC AGT CTT CTG GGT GGC AGT GAT -3’), cd18
(cd18; 5'-CGG TCT TCG ACT TGA AGT GAC CTG-3' and 5'-GGG TCC ATG ATA
TCA TCG GC-3') and cd11b (cd11b; 5'-GGG TCC AGA AAC CTA ACT ACG TC-3'
and 5'-CCA GTG TAT AAT TGA GGC GC-3') in an Mx3005P® QPCR System
(Stratagene, La Jolla, CA) and SYBR green-containing reaction buffer (Roche, Nutley,
NJ). Relative expression of the gene is referred to non-activated RAW264.7 cells.
We confirmed elevated levels of CR3 expression by RAW264.7 cells following
activation with IFNγ by flow cytometry and fluorescence microscopy. Following
activation with rmIFNg, RAW264.7 cells were harvested and washed with PBS before
incubation with FITC-conjugated rat anti-mouse CD11b (BD Pharmingen) for 30 minutes
at 4ºC. The cells were next washed extensively and resuspended in PBS supplemented
with 10% FCS and analyzed by flow cytometry for the expression of CR3.
For the microscopic analysis of CR3 expression, the IFNγ-activated or nonactivated cells were washed extensively and fixed in 3.7% para-formaldehyde for 7
minutes and then washed with PBS, as described. Following blocking of non-specific
binding with 5% BSA for 60 minutes, the cells were stained with FITC-conjugated rat
anti-mouse CD11b (Molecular Probes) for 60 minutes at 37ºC and DAPI, as described
before. After extensive washing in PBS, the cells were mounted and analyzed.
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Statistical analysis
The results are presented as means ± SE. Significant differences between means
were calculated with the Student’s t test. P values of 0.05 or less were considered
statistically significant.
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Results and Discussion
Complement opsonization enhances phagocytosis of B. burgdorferi in a CR3dependent fashion

The binding of complement-opsonized B. burgdorferi to human neutrophils has
been shown to occur via a CR3-dependent mechanism (29). CR3-mediated phagocytosis
of B. burgdorferi might be a particularly relevant mode of bacterial clearance during
initial deposition of the spirochete into the skin and also during disseminated disease.
This is because B. burgdorferi express surface exposed proteins that halt the terminal
complement cascade by cleaving and inactivating C3b. This process generates iC3b, a
serum opsonin and ligand for CR3, in close proximity to the pathogen. We therefore
tested the role of complement opsonization in the phagocytosis of B. burgdorferi by
murine BMMs. Incubation of GFP-expressing B. burgdorferi with BMMs in the presence
of 10% normal mouse serum (NMS) greatly increases the amount of phagocytosis, as
determined by immunofluorescence microscopy and flow cytometric analysis (Figures
2.1A and B). To determine the contribution of CR3 and CR4 in mediating the interaction
with complement opsonized B. burgdorferi, we utilized CHO cells expressing either CR3
or CR4. Our results demonstrate that CR3 but not CR4 binds complement-opsonized B.
burgdorferi, as previously demonstrated (29) (Figure 2.1C). Using a CR3 blocking
antibody directed to the CD11b beta chain, we determined the contribution of CR3 to the
phagocytosis of serum opsonized B. burgdorferi by RAW264.7 macrophage-like cells.
The enhanced level of phagocytosis of B. burgdorferi in the presence of complement was
abrogated by CR3 blocking, indicating that CR3 is the primary complement receptor
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involved in the phagocytosis of complement opsonized B. burgdorferi (Figure 2.1D). Our
results also show residual binding of B. burgdorferi to CHO-CR3 cells in the presence of
heat-inactivated serum (Figure 2.1C), suggesting that CR3 may represent a means of
interacting with B. burgdorferi at the host-cell/spirochete interface in the absence of
complement. Furthermore, CR3 blocking reduced the level of B. burgdorferi
phagocytosis in the presence of heat-inactivated NMS (Figure 2.1D), suggesting that this
receptor may mediate the phagocytosis of the spirochete through a direct interaction.
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Figure 2.1. Complement opsonization enhances phagocytosis of B. burgdorferi in a
CR3-dependent fashion.
(A) Microscopic and (B) flow cytometric analysis of B. burgdorferi phagocytosis
by BMMs in the absence or presence of 10% NMS. F4/80 (red) was used as a cellsurface marker and Dapi (blue) was used to stain the nucleus. (C) Increased B.
burgdorferi interaction with CR3-expressing CHO cells in the presence of active or heatinactivated 10% NMS. (D) Anti-CD11b antibodies (10 µg/ml) inhibit the phagocytosis of
B. burgdorferi by RAW264.7 cells in the presence of 10% NMS. Heat-inactivated serum
was used to control for phagocytosis of B. burgdorferi proceeding in the absence of
complement opsonization. A 4º binding control (solid gray histogram) was included and
consists of B. burgdorferi incubated with RAW264.7 cells in the presence of 10% NMS.
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CR3 is a receptor for B. burgdorferi
Our assessment of the interaction between CR3 and B. burgdorferi in the absence
of serum consisted of a combination of apotome microscopy and flow cytometry, as
previously described (104). Our results show that CHO cells expressing CR3 acquire the
ability to interact directly with B. burgdorferi, because CHO-CR3 but not CHO-CR4
cells are positive for GFP fluorescence, above background binding, as determined by
flow cytometric analysis (Figures 2.2A and B). In order to further elucidate the nature of
the interaction between CR3 and B. burgdorferi, we analyzed the interaction of B.
burgdorferi with CR3- or CR4-expressing CHO cells by fluorescence microscopy. These
data confirmed our flow cytometric finding that CR3 facilitates the interaction of B.
burgdorferi to CHO cells, but further suggested that CR3 expression alone is unable to
confer phagocytic capacity to these cells (Figure 2.2C), because the spirochetes sustained
their elongated morphology consistent with extracellular localization. We therefore
utilized an immunoglobulin (Ig) protection assay to determine whether CHO cells
expressing CR3 are able to internalize B. burgdorferi. In this Ig protection assay,
internalized spirochetes are protected from B. burgdorferi-specific Ig and therefore
remain only GFP-positive while extracellular spirochetes will be stained with mouse B.
burgdorferi-specific Ig and anti-mouse alexafluor 594 and therefore will be doublepositive. Using this approach, we were unable identify CHO-CR3 cells that had
internalized B. burgdorferi, indicating that CR3 is able to mediate cellular binding to B.
burgdorferi but is not sufficient for phagocytosis of spirochete (Figure 2.2D).

The most important integrin domain in ligand binding is the inserted (I) domain
(84), which contains at their apex a metal-binding site known as the metal-ion-depending
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adhesion site or MIDAS. The active conformation of CR3 requires the presence of a
divalent cation in the inserted domain coordinated by the MIDAS. Mg2+ is the
physiological metal that comprises integrin MIDAS, but Mn2+ is also able to orchestrate
ligand binding in CR3 (82, 84, 97). Because CR3 binding to B. burgdorferi is disrupted
by anti-CD11b antibody directed to the inserted domain (data not shown) and was
previously shown not to depend on the lectin domain of CR3 (29), we tested whether this
binding was dependent on free divalent cation. Using EDTA, a divalent cation chelator,
we were able to completely disrupt the binding between CHO-CR3 cells and B.
burgdorferi, indicating that CR3 MIDAS is required for binding to B. burgdorferi (Figure
2.2E).
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Figure 2.2. CR3 is a receptor for B. burgdorferi.
(A) Flow cytometric analysis of B. burgdorferi interaction with CR3- or CR4expressing CHO cells after 6h at an MOI of 10 or 100. Result is a single representative of
three independent experiments. (B) Average percentage of B. burgdorferi associated
CHO-CR3 and CHO-CR4 cells obtained from three separate experiments. (C)
Microscopic analysis of CHO-CR3 or CHO-CR4 cellular interaction with B. burgdorferi.
Cells were incubated with GFP-expressing B. burgdorferi at an MOI of 100. Rhodamine
phalloidin was used to actin filaments (red) and the nucleus (blue) was stained with Dapi.
(D) CHO-CR3 cells were incubated with GFP-expressing B. burgdorferi at and MOI of
100 and extracellular spirochetes were stained with B. burgdorferi-infected mouse serum
followed by anti-mouse IgG 594. The nucleus was stained with Dapi. (E) CHO-CR3 cells
were incubated with B. burgdorferi at an MOI of 100 in the absence or presence of 1mM
EDTA.
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Phagocytosis of B. burgdorferi by macrophages is mediated by CR3
Since CR3 is able to facilitate the attachment of B. burgdorferi to CHO cells
(Figure 2.2), we hypothesized that CR3-mediated attachment could be important for
phagocytosis of the spirochete by professional phagocytes, such as macrophages, in the
absence of serum opsonization. We therefore determined the contribution of CR3 to the
phagocytosis of B. burgdorferi by RAW264.7 macrophage-like cells by using the CR3
blocking antibody that we previously demonstrated was able to disrupt the attachment of
B. burgdorferi to CHO-CR3 cells and serum opsonized B. burgdorferi to RAW264.7
cells. Anti-CD11a or -CD11c control antibodies do not affect phagocytosis of B.
burgdorferi, while the presence of 5 µg/ml of anti-CD11b antibody results in a reduction
in phagocytosis by approximately 50%, compared to the control group, as determined by
flow cytometric analysis (Figure 2.3A) and microscopic analysis (Figure 3.3B). These
data indicate that binding of B. burgdorferi by CR3 is important in mediating the
phagocytosis of the spirochete by RAW264.7 cells.
We next determined the contribution of CR3 in the phagocytosis of B. burgdorferi
by bone marrow-derived macrophages, using RAW264.7 cells for comparison. The effect
of the blocking antibody on the phagocytosis of B. burgdorferi by RAW264.7 cells is
dose-dependent with complete inhibition occurring between 10-20 µg/ml of anti-CD11b
(Figure 2.4A), underscoring the importance of this receptor in the phagocytosis of B.
burgdorferi in this cell type. Importantly, the chelation of divalent cation with EDTA is
also able to fully prevent phagocytosis of B. burgdorferi (Figure 2.4B), as expected.
Although the effect of the blocking antibody on the phagocytosis of the spirochete by
BMMs is also dose-dependent, the amount of inhibition is not as pronounced (Figure
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2.4C). Even at a moderately high concentration, the effect of the blocking antibody on the
phagocytosis of B. burgdorferi does not appear to reach a saturating level. Arguing that
higher expression of the receptor requires a higher concentration of blocking antibody to
achieve a similar level of inhibition between the two cell types, we determined the level
of surface CR3 expression between RAW264.7 cells and BMMs. Indeed, expression of
CR3 is more than 1 order of magnitude higher in BMMs, compared to RAW264.7 cells
and EDTA does not affect CR3 expression in either cell type (Figure 2.4E). Moreover,
the presence of EDTA is able to fully inhibit the phagocytosis of B. burgdorferi by
BMMs when used at the same concentration with RAW264.7 cells (Figure 2.4D). We
therefore utilized CD11b-deficient BMMs in our study to eliminate the effect of variable
CR3 expression. Using CD11b-deficient macrophages, we are able to demonstrate that
phagocytosis of B. burgdorferi is at least partially dependent on the presence of CR3
(Figure 2.4F).
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Figure 2.3. CR3 mediates phagocytosis of B. burgdorferi by RAW264.7 cells.
(A) Flow cytometric analysis or (B) microscopic analysis of RAW264.7 cell
phagocytosis of B. burgdorferi in the presence of 5 µg/ml anti-CD11a, anti-CD11b or
anti-CD11c at an MOI of 50 for 4h. A 4º control was used to determine backgroundbinding levels. For microscopic analysis, rhodamine phalloidin was used to stain actin
filaments (red) and the nucleus (blue) was stained with Dapi.
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Figure 2.4. CR3 partially mediates the phagocytosis of B. burgdorferi by BMMs.
RAW264.7 macrophages were incubated with GFP-expressing B. burgdorferi at
an MOI of 50 for 4h in the absence (black histogram) or presence of increasing
concentrations of (A) anti-CD11b antibody (green histogram) or (B) in the absence or
presence of 1 mM EDTA. The shaded histogram indicates the 4º control. (C) Analysis of
BMM phagocytosis of B. burgdorferi in (C) the presence of increasing concentrations
anti-CD11b blocking antibody or (D) EDTA, as before, with the exception that
spirochetes were used at an MOI of 10. (E) Analysis of CR3 expression in RAW264.7
cells (green) and BMMs (blue) in the absence (solid histogram) or presence (dotted
histogram) of 1 mM EDTA. (F) Widltype (black) and CR3-deficient BMMs (red) were
incubated with B. burgdorferi at MOIs of 1 and 10, as before. For A-E, results depicted
are representative of at least 3 experiments. For F, results are representative of 2
experiments.
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IFNγ upregulates CD11b and CD18 transcription resulting in increased CR3 cell
surface expression and phagocytosis of B. burgdorferi
We previously reported that IFNγ enhances phagocytosis of B. burgdorferi by
RAW264.7 cells and BMMs (104). Although this phenomenon has important biological
consequences in terms of infection, the mechanism underlying the IFNγ-mediated
increase in spirochete phagocytosis is unknown. Now with a potential target, we
determined the effect that IFNγ has on the expression of CD11b and CD18 by RAW264.7
cells. Quantitative RT-PCR analysis of CD11b and CD18 in macrophages revealed that
both of these transcripts were upregulated in response to IFNγ activation (Figure 2.5A).
Since IFNγ increased CD11b and CD18 transcription, we next assessed the level of CR3
protein on the surface of RAW264.7 cells. Microscopic analysis revealed that CR3
expression is increased following activation with IFNγ, compared to non-activated
control cells (Figure 2.5B). This finding was confirmed by flow cytometric analysis,
which also demonstrated increased CR3 surface staining following IFNγ activation
(Figure 2.5C).
Because increased cell surface expression of CR3 could account for the IFNγmediated increase in the phagocytosis of B. burgdorferi, we next determined the
contribution of CR3 to the phagocytosis of B. burgdorferi by macrophages activated with
IFNγ. As previously shown, IFNγ activation enhances the phagocytosis of B. burgdorferi
by RAW264.7 cells (Figures 2.5D and E). However, the presence of anti-CD11b
blocking antibodies significantly decreased the phagocytosis of B. burgdorferi by both
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IFNγ-activated and non-activated RAW264.7 cells (Figures 2.5D and E). Importantly,
our data demonstrate that the effect of IFNγ on the phagocytosis of B. burgdorferi is
circumscribed to CR3 activity because disruption of CR3-mediated phagocytosis reduces
phagocytosis to the same level in both IFNγ-activated and non-activated cells (Figures
2.5D and E).
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Figure 2.5. IFNγ increases phagocytosis of B. burgdorferi through transcriptional
upregulation of CR3
(A) Quantitative real-time PCR analysis of CD11b and CD18 expression
following activation RAW264.7 macrophages with (empty bars) or without (black bars)
rmIFNγ for 12h. Determination of CR3 expression by fluorescence microscopy (B) and
flow cytometry (C) following activation with or without rmIFNγ. For (C), the dashed line
represents IFNγ-activated cells, and the gray line represents the non-activated cells. (D)
Flow cytometric analysis of the role of CR3 in IFNγ-mediated enhancement of B.
burgdorferi phagocytosis. Spirochetes were incubated with RAW264.7 cells at an MOI
of 50 for 4h in the presence or absence of 50ng/ml rmIFNγ, as before. Anti-CD11b
blocking antibody (red bar) or control anti-CD11c antibody (black bar) was used at 10
µg/ml. The gray histogram is the 4ºC control and represents background binding. The
results depicted here are representative of three experiments. (E) Graphical analysis of
the average percentage of cells positive for B. burgdorferi phagocytosis. Results depicted
are the average of 3 experiments. * Student’s T test, p<0.05
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CR3 is a negative regulator of proinflammatory cytokine induction in response to B.
burgdorferi
Innate recognition of B. burgdorferi is mainly controlled by TLR1/2 complexes
and results in the activation of an inflammatory gene profile. Having identified CR3 as a
bonafide receptor for the spirochete, we next determined the contribution of the CR3-B.
burgdorferi interaction to the TLR1/2-mediated response against B. burgdorferi by
measuring the secretion of TNF in wildtype, TLR2- and CD11b-deficient BMMs. The
secretion of TNF by wildtype BMMs challenged with live B. burgdorferi is almost
completely abrogated in TLR2-deficient macrophages, confirming the predominant role
for TLR1/2 complexes in the inflammatory response against the spirochete (Figure 2.6A).
However, CD11b-deficient macrophages respond more vigorously to the spirochete
compared to wildtype macrophages (Figure 2.6A), suggesting that CR3 is a negative
regulator of TLR-induced TNF secretion. We next analyzed the contribution of CR3mediated signals derived from iC3b-opsonized B. burgdorferi to the secretion of TNF.
Although phagocytosis of live B. burgdorferi potentiates TNF secretion, as compared to
sonicated B. burgdorferi, and complement-opsonization increases phagocytosis of B.
burgdorferi in a CR3-dependent fashion (Figure 2.1A-C), complement-opsonization
significantly reduces the secretion of TNF by BMMs responding to live and sonicated B.
burgdorferi (Figure 2.6B; Student t test; p < .05; n = 5). Furthermore, the effect of
complement-opsonization on TNF secretion in response to live and sonicated B.
burgdorferi was reversed by complement component C3-deficiency (Figure 2.6B),
supporting a role for CR3 as a negative regulator of proinflammatory cytokine secretion
in response to B. burgdorferi. Therefore, although phagocytosis of B. burgdorferi
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potentiates the secretion of inflammatory cytokines (35), our data indicate that a B.
burgdorferi phagocytic receptor, CR3, serves to modulate the TLR-mediated response
against the spirochete by dampening the secretion of TNF.
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Figure 2.6. CR3 is a negative regulator of cytokine induction in macrophages
responding to B. burgdorferi.
(A) BMMs obtained from wildtype, TLR2-deficient or CD11b-deficient mice were
incubated with B. burgdorferi at an MOI of 10 or 50 for 6h. TNF secretion was analyzed
by ELISA. Results depicted are from a single experiment. (B) BMMs were incubated
with live or sonicated B. burgdorferi at an MOI of 10 in the absence or presence of 10%
NMS obtained from wildtype or C3-deficient mice. TNF secretion was determined by
ELISA, as before. Results are representative of 5 (live B. burgdorferi) and 3 (sonicated B.
burgdorferi) experiments.
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CHAPTER IV
CONCLUSION
Invariant natural killer T cell responses are important for host protection during a
variety of microbial infections (75). The discovery that B. burgdorferi-derived
diacylglycerol glycolipids act as natural antigens to Vα14- and Vα24i NKT cells is the
sole demonstration of an Vα14-Jα18i NKT cell antigen expressed by a human pathogen
(68). The experimental infection of CD1d-deficient mice, which lack Vα14-Jα18i NKT
cells, with B. burgdorferi also suggested their potential involvement in the genesis of
inflammation during Lyme borreliosis. The absence of CD1d results in augmented B.
burgdorferi levels in the urinary bladder of infected mice, in addition to increased Lyme
arthritis incidence and severity (76), while the effect of CD1d-deficiency on Lyme
carditis was not reported. However, these findings could not be assigned exclusively to
Vα14-Jα18i NKT cell function, since CD1d-deficiency also leads to the lack of CD1dreactive cells other than Vα14-Jα18i NKTs (26, 27, 76). Furthermore, CD1d-deficient
mice have impaired marginal zone B cell function (10), which may also affect the
systemic response to the spirochete. These findings prompted us to examine the specific
role of Vα14-Jα18i NKT cells in the pathogenesis of Lyme disease.
Our studies, using a mouse line deficient for a component of the invariant alpha
TCR, which specifically precludes the development of Vα14-Jα18i NKT cells in the
thymus (75), show that infection of Jα18-deficient mice with B. burgdorferi results in
higher pathogen burden in the heart and, as a consequence, more severe Lyme carditis.
Although Vα14-Jα18i NKT cells are able to potentiate B cell responses to various
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pathogens (127), our data indicate that this does not occur during infection with B.
burgdorferi. Furthermore, Jα18-deficient mice infected with B. burgdorferi did not
develop an altered Th1 response to B. burgdorferi antigens, as determined by antigenspecific restimulation experiments. Thus, the effect of Vα14-Jα18i NKT-deficiency on
the pathogenesis of murine Lyme disease is likely the result of the modulation of cell
responses at sites of acute inflammation and not in secondary lymphoid organs. Indeed,
we show that spirochete colonization and expansion in the heart leads to cardiac
inflammation, which is marked by the migration to the heart of CD3+ T cells as well as
CD1d- and CD11b- antigen presenting cells, while no infiltration of CD11c+ cells was
detected (data not shown). Our data show that CD3+ T cells include Vα14-Jα18i NKT
and other T cells (CD4+ and/or γδ T cells), because Jα18-deficient infected hearts still
contained CD3+ cells (data not shown).
Since B. burgdorferi glycolipid-pulsed dendritic cells induce IFNγ production by
Vα14-Jα18i NKT cells in vivo (68), we tested the contribution of these cells to the pool
of IFNγ mRNA found in the hearts of B. burgdorferi-infected mice. Our results show that
induction of ifnγ gene expression in the hearts of B. burgdorferi-infected mice was almost
completely abrogated in Jα18-deficient mice 2 weeks post infection, indicating that
Vα14-Jα18i NKT cells are critical for generating an IFNγ response in vivo during the
peak of disease. Reports have suggested that an intact IFNγ response is important for
controlling pathogenesis of Lyme carditis and not Lyme arthritis (16, 20, 22, 52).
Although the presence of T cells is not sufficient to prevent the onset of Lyme carditis
(93), CD4+ T cells mediate the regression of murine Lyme carditis (16). Consistent with
this, our results demonstrate that Vα14-Jα18i NKT cells are important for controlling the
70

severity of inflammation in the heart; a phenomenon circumscribed to their role in the
production of IFNγ and modulation of the macrophage response to B. burgdorferi. Thus,
we propose that the similar disease phenotype between IFNγRα- and Jα18-deficient mice
is explained by the critical contribution of Vα14-Jα18i NKT cells to the pool of IFNγ
found in the hearts of B. burgdorferi-infected mice.
Studies have reported great variation among different inbred strains of mice in
terms of the presence of Vα14-Jα18i NKT cells in different organs and their capacity to
respond to antigen (116). Among a large panel of strains tested, Vα14-Jα18i NKT cells
from B6 mice showed the highest production of cytokines and the fastest response
kinetics to the prototypical ligand αGalCer (116). Since B6 mice are less susceptible to
inflammation than C3H mice (141), and due to the difference in the number of Vα14Jα18i NKT cells and their response to specific antigen among these strains, it is tempting
to speculate that the differential susceptibiltity to cardiac inflammation is associated with
the presence and capacity of Vα14-Jα18i NKT cells to respond to B. burgdorferi
antigens. Indeed, Tupin and coworkers recently demonstrated that iNKT cells do not
migrate to the inflamed hearts of B. burgdorferi-infected BALB/c mice, and that Jα18deficient mice on the BALB/c background are not more susceptible to the development
of Lyme carditis upon infection with B. burgdorferi (129). Whether these differences in
quantity and/or their capacity to respond to antigen are also present in human subjects
remains to be elucidated.
A mechanism underlying IFNγ-mediated control of B. burgdorferi pathogenesis
has not been determined. Since macrophages are the predominant leukocyte of the
inflamed heart (115) and IFNγ activation of macrophages has been shown to enhance
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their response to various pathogens (119), we determined the effect that IFNγ had on the
macrophage response to B. burgdorferi. Our results indicate that IFNγ greatly enhances
proinflammatory cytokine production by macrophages challenged with live B.
burgdorferi. Most notably, IFNγ enhanced the phagocytic capacity of macrophages,
suggesting their role in spirochete clearance at sites of active inflammation, such as the
heart. This is an interesting observation given that IFNγ has historically been regarded as
a cytokine with a biological activity confined to the response to intracellular pathogens,
including viruses, bacteria and parasites. Here, we show that IFNγ is important for
protection against the extracellular spirochete, B. burgdorferi. The lack of involvement of
IFNγ in the pathogenesis of Lyme arthritis might be explained by the cellular profile of
the inflammatory infiltrate. Indeed, lesions in the heart of B. burgdorferi infected mice
are predominantly comprised of macrophages, while neutrophils are primarily found in
the joint. The contribution of cell types such as synoviocytes, chondrocytes and other
cells (9, 142) to joint but not heart inflammation further distinguish both inflammatory
phenomena. As a consequence of the more complex cellular interplay, iNKT cell
responses to B. burgdorferi in the joint might not be as effective at controlling Lyme
arthritis.
These studies define the role of Vα14-Jα18i NKT cells in the host response
elicited against the Lyme disease spirochete, B. burgdorferi. Our results show that Vα14Jα18i NKT cells migrate to the inflamed heart of B. burgdorferi-infected mice and are
exposed to an environment conducive for their activation by B. burgdorferi glycolipids.
Activation of Vα14-Jα18i NKT cells is critical for the induction of IFNγ, which enhances
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macrophage effector functions required for efficient clearance of B. burgdorferi from the
inflamed heart and the sustained activation of Vα14-Jα18i NKT cells.

The etiology of Lyme disease is not well understood. This is due, in part, to the
complex interplay between different cell types, which varies depending on the affected
site. Because macrophages are the principal immune cells found in the heart during
experimental infection with B. burgdorferi (104, 115), the interaction between the
macrophage and the spirochete has important consequences in terms of pathogenesis of
Lyme carditis. However, the identification of a receptor that lies at the interface between
the spirochete and macrophage and is able to mediate phagocytosis has remained elusive.
Here we have identified the β2 integrin, CR3, as a receptor able to mediate the
phagocytosis of B. burgdorferi in a complement- dependent and -independent manner
and that CR3-dependent phagocytosis of B. burgdorferi is enhanced by activation with
IFNγ.
One of the main endogenous ligands of CR3 is the complement component iC3b
(inactivated C3b), which is a serum opsonin with broad-range specificity for pathogens.
Previous work demonstrated a role for CR3 in the phagocytosis of complement opsonized
B. burgdorferi (29) by human neutrophils. Initial experiments here were in agreement
with those findings because the phagocytosis of B. burgdorferi by RAW264.7
macrophage-like cells and BMMs was dramatically enhanced by complement
opsonization. Complement opsonization is not required for the phagocytosis of B.
burgdorferi, however, and the addition of anti-CD11b blocking antibodies reduced the
phagocytosis of complement-opsonized B. burgdorferi to levels below that achieved with
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non-opsonized B. burgdorferi, suggesting that CR3 mediates the phagocytosis of B.
burgdorferi in a complement-dependent and independent manner.
When CHO cells were transfected with CR3 they acquired the ability to interact
with B. burgdorferi, in the absence of complement opsonization. Studies using different
pathogens, including N. meningitidis (66) and B. anthracis spores (102), showed that
CR3 expression alone conferred phagocytic capacity for these pathogens to CHO cells.
This is in contrast to our findings using B. burgdorferi, which show that the interaction
between CR3-expressing CHO cells and B. burgdorferi is not productive in terms of
phagocytosis, but instead is critical for attachment of the spirochete to the cell. These
results indicated that CR3 is a B. burgdorferi receptor and suggested that the interaction
between B. burgdorferi and CR3 might result in internalization of B. burgdorferi by a
phagocytic cell.
Our studies using RAW264.7 cells demonstrated that inhibition of CR3 with
blocking antibody was able to completely abrogate phagocytosis of B. burgdorferi. Thus,
CR3-mediated binding is a requirement for phagocytic uptake in this cell type.
Interestingly, however, BMM phagocytosis of B. burgdorferi was only partially affected
by inhibition of CR3-mediated binding, but completely blocked by the non-specific
divalent cation chelator EDTA, suggesting the presence of alternative receptors that
mediate binding through divalent cations. C-type lectins are a family of PRRs, including
phagocytic receptors, whose binding to ligands usually proceeds in a Ca2+ dependent
fashion. The mannose receptor (MR) is a C-type lectin that has been shown to mediate
the binding of B. burgdorferi to human monocyte-derived macrophages (28). We
speculate the involvement of MR in BMM phagocysosis of B. burgdorferi, based on the
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complete abrogation of phagocytosis in the presence of EDTA. In contrast, RAW264.7
cell phagocytosis of B. burgdorferi is completely dependent on CR3. Importantly,
preliminary studies in our lab have demonstrated that BMMs but not RAW264.7 cells
express MR.
CR3 is a promiscuous receptor that recognizes an array of host and microbial
ligands. Outer surface lipoproteins A and B (OspA and OspB) are two major molecular
constituents of B. burgdorferi, which contribute to the maintenance of the spirochete in
nature but whose expression is downregulated during transmission into a mammalian
host. These proteins were shown to bind to CR3 in an iC3b-independent fashion,
suggesting that they may drive CR3-mediated phagocytosis (48). Moreover, experimental
infection with an OspA/B-deficient mutant led to higher bacterial loads in the joint and
more pronounced Lyme arthritis (143). An evaluation of Lyme carditis was not made in
this study, but proliferation of the OspA/B mutant in the heart was statistically similar to
that of the wildtype B. burgdorferi (143). Current studies are determining the contribution
of Osps A and B to the phagocytosis of B. burgdorferi and whether this is dependent on
an interaction with CR3. Preliminary results suggest that in BMMs the expression of
Osps A and B are dispensible for the phagocytosis of the spirochete.
We and others have shown that IFNγ-signaling is important for controlling the
severity of Lyme carditis (16, 20, 22, 52, 104) via the modulation of macrophagemediated phagocytosis of B. burgdorferi (104). We show here that activation of
macrophages with IFNγ resulted in upregulation of both components of CR3, CD11b and
CD18, at the transcriptional level and that this correlated with increased cell surface
expression of CR3. Importantly, the effect of IFNγ on the phagocytosis of B. burgdorferi
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was completely diminished in the presence of CR3 blocking antibodies, indicating that
the role of IFNγ in the phagocytosis of B. burgdorferi is circumscribed to the activity of
CR3.

Macrophages express unique combinations of PRRs, which likely result in tissuespecific responses to pathogen (64). Because we defined CR3 as a receptor for B.
burgdorferi, we were interested in the role of CR3 in defining the proinflammatory
response to the spirochete. Our results indicate that CR3 is a negative regulator of the
TLR1/2-induced signals elicited by B. burgdorferi, even in the context of complement.
This is in contrast to most pathogens, in which complement opsonization increases the
proinflammatory response and therefore our results warrant further investigation.
In summary, we have defined the contribution of the complement receptor CR3 to
the phagocytosis of the Lyme disease spirochete, B. burgdorferi. Our results place CR3
as a central PRR involved in the recognition of B. burgdorferi by macrophages, because
CR3 is able to mediate the phagocytosis of the spirochete. Our results also demonstrate
that IFNγ regulates phagocytosis of B. burgdorferi by controlling the transcriptional
activation of the components of CR3, CD11b and CD18. Furthermore, our results
indicate CR3 is a negative regulator of TLR-induced proinflammatory signals elicited in
response to B. burgdorferi both in the presence and the absence of complement
opsonization. Taken together, these data shed light on the role of IFNγ and CR3 in
macrophage-mediated control of spirochete expansion during Lyme borreliosis.
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